Article
Review of Experimental Compounds Demonstrating Anti-Toxoplasma Activity
7 Sept 2016
Abstract excerpt
Toxoplasma gondii is a ubiquitous apicomplexan parasite capable of infecting humans and other animals. Current treatment options for T. gondii infection are limited and most have drawbacks, including high toxicity and low tolerability. Additionally, no FDA-approved treatments are available for pregnant women, a high-risk population due to transplacental infection. Therefore, the development of novel treatment...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
